Head and neck mesenchymal neoplasms with GLI1 gene alterations: A pathologic entity with distinct histologic features and potential for distant metastasis Journal Article


Authors: Xu, B.; Chang, K. P.; Folpe, A. L.; Kao, Y. C.; Wey, S. L.; Huang, H. Y.; Gill, A. J.; Rooper, L.; Bishop, J. A.; Dickson, B. C.; Lee, J. C.; Antonescu, C. R.
Article Title: Head and neck mesenchymal neoplasms with GLI1 gene alterations: A pathologic entity with distinct histologic features and potential for distant metastasis
Abstract: Soft tissue tumors with GLI1 gene fusions or amplifications have been recently described as a unique pathologic entity with an established risk of malignancy. We herein expand these findings by investigating a cohort of 11 head and neck lesions with GLI1 alterations, including 8 from the tongue, for their clinicopathologic and molecular features. The tumors commonly affected males in their 30s (male:female ratio 2.7:1; range: 1 to 65). Tumors showed a multinodular growth pattern, nested architecture separated by a delicate, arborizing vascular network, monotonous round to ovoid nuclei, and clear cytoplasm. Tumor protrusion into vascular spaces was common. Genetic alterations were investigated by fluorescence in situ hybridization and/or targeted RNA sequencing. Seven tumors harbored GLI1 fusions with the following partners: ACTB (n=4), PTCH1 (n=2), or MALAT1 (n=1). The remaining 4 cases showed coamplifications of GLI1 with CDK4 and MDM2 genes. Tumors were commonly positive for S100 protein and CD56. CDK4, MDM2, and STAT6 were positive in GLI1-amplified tumors. Two of 6 patients with available follow-up (1 each with GLI1 amplification and PTCH1-GLI1 fusion) developed distant metastases. Both tumors showed a high mitotic index and tumor necrosis. The head and neck region, particularly tongue, is a common location for GLI1-related mesenchymal tumors. Although a morphologic overlap was noted with the previously reported "pericytoma with t(7,12) translocation," often occurring in the tongue, our findings expand the original findings, to include a more variable immunophenotype, propensity for late distant metastases, and alternative mechanisms of GLI1 oncogenic activation, such as various GLI1 fusion partners or GLI1 coamplifications with MDM2 and CDK4 genes.
Keywords: tumor; expression; malat1; ptch1; actb; pericytoma; actb-gli1 fusion; t(7/12); gli1 amplification; gli1 fusion
Journal Title: American Journal of Surgical Pathology
Volume: 44
Issue: 6
ISSN: 0147-5185
Publisher: Lippincott Williams & Wilkins  
Date Published: 2020-06-01
Start Page: 729
End Page: 737
Language: English
ACCESSION: WOS:000536254200002
DOI: 10.1097/pas.0000000000001439
PROVIDER: wos
PMCID: PMC7225037
PUBMED: 31934916
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Cristina R Antonescu
    895 Antonescu
  2. Bin   Xu
    227 Xu